Objetivo Analizar la incidencia y los resultados visuales de cada uno de los subtipos de lesión neovascular en pacientes con degeneración macular asociada la edad (DMAE). Material y métodos Revisión retrospectiva de pacientes con DMAE neovascular tratados en el Hospital Universitario y Politécnico la Fe de Valencia por un mismo retinólogo (RGP) desde diciembre de 2012 hasta julio del 2015. Se registraron las formas anatómicas del complejo neovascular, así como el número de tratamientos intravítreos administrados y el cambio de visión obtenido con este. Resultados Fueron incluidos 174 ojos de 156 pacientes con una edad media de 79,9 años y un seguimiento de al menos 4 meses. El 40,8% presentaban neovascularización coroidea (NVC) tip...
PURPOSE: To investigate the clinical characteristics and therapeutic outcome of patients with neovas...
La DMAE es la principal causa de ceguera en pacientes por encima de los 65 años. La investigación de...
Purpose To review treatment strategies in neovascular age-related macular degeneration (ARMD). Me...
Purpose. To survey the management of patients with neovascular age-related macular degeneration (nvA...
PURPOSE: To determine the frequency of neovascularization subtypes as determined by fluorescein angi...
Se realizó el estudio de 10 pacientes diagnosticados con degeneración macular relacionada con la eda...
Propósito: Analizar las características morfológicas del material hiperreflectivo subretiniano (MHRS...
OBJETIVOS: Avaliar a função macular por eletrorretinografia focal e angiofluoresceinografia em pacie...
Purpose. To evaluate the effects of anti-VEGF treatment of neovascular age-related macular degenerat...
International audiencePURPOSE: This study aimed to estimate the incidence and prevalence of neovascu...
PURPOSE: To describe the preclinical and very early stages of type 3 neovascularization using multi...
Purpose: To analyze the frequency and phenotypic variation of AMD in subjects with high myopia (HM)...
PURPOSE: To investigate the incidence of fellow eye (FE) neovascular age-related macular degenerati...
Intravitreal antivascular endothelial growth factor drugs represent the current standard of care for...
Journal Article;Purpose. To survey the management of patients with neovascular age-related macular d...
PURPOSE: To investigate the clinical characteristics and therapeutic outcome of patients with neovas...
La DMAE es la principal causa de ceguera en pacientes por encima de los 65 años. La investigación de...
Purpose To review treatment strategies in neovascular age-related macular degeneration (ARMD). Me...
Purpose. To survey the management of patients with neovascular age-related macular degeneration (nvA...
PURPOSE: To determine the frequency of neovascularization subtypes as determined by fluorescein angi...
Se realizó el estudio de 10 pacientes diagnosticados con degeneración macular relacionada con la eda...
Propósito: Analizar las características morfológicas del material hiperreflectivo subretiniano (MHRS...
OBJETIVOS: Avaliar a função macular por eletrorretinografia focal e angiofluoresceinografia em pacie...
Purpose. To evaluate the effects of anti-VEGF treatment of neovascular age-related macular degenerat...
International audiencePURPOSE: This study aimed to estimate the incidence and prevalence of neovascu...
PURPOSE: To describe the preclinical and very early stages of type 3 neovascularization using multi...
Purpose: To analyze the frequency and phenotypic variation of AMD in subjects with high myopia (HM)...
PURPOSE: To investigate the incidence of fellow eye (FE) neovascular age-related macular degenerati...
Intravitreal antivascular endothelial growth factor drugs represent the current standard of care for...
Journal Article;Purpose. To survey the management of patients with neovascular age-related macular d...
PURPOSE: To investigate the clinical characteristics and therapeutic outcome of patients with neovas...
La DMAE es la principal causa de ceguera en pacientes por encima de los 65 años. La investigación de...
Purpose To review treatment strategies in neovascular age-related macular degeneration (ARMD). Me...